ABN AMRO Investment Solutions’s DexCom DXCM Stock Holding History

ABN AMRO Investment Solutions’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5M	Buy	39,851 +433	+1%	+$30.2K	0.03%	308
2025 Q4	$2.62M	Buy	39,418 +4,319	+12%	+$279K	0.04%	279
2025 Q3	$2.36M	Buy	35,099 +30,649	+689%	+$2.43M	0.05%	238
2025 Q2	$388K	Buy	4,450 +441	+11%	+$34.6K	0.01%	365
2025 Q1	$274K	Sell	4,009 -4,053	-50%	-$331K	0.01%	391
2024 Q4	$627K	Buy	8,062 +2,346	+41%	+$174K	0.01%	332
2024 Q3	$383K	Sell	5,716 -29,018	-84%	-$2.38M	0.01%	419
2024 Q2	$3.94M	Buy	34,734 +12,319	+55%	+$1.56M	0.07%	175
2024 Q1	$3.11M	Buy	22,415 +642	+3%	+$80.7K	0.05%	216
2023 Q4	$2.7M	Buy	21,773 +20	+0.1%	+$2.04K	0.05%	231
2023 Q3	$2.03M	Buy	21,753 +13,032	+149%	+$1.47M	0.04%	249
2023 Q2	$1.12M	Sell	8,721 -300	-3%	-$36.3K	0.02%	282
2023 Q1	$1.05M	Buy	+9,021	New	+$1.01M	0.02%	303

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ABN AMRO Investment Solutions's DXCM Position: Q1 2026 in Review

ABN AMRO Investment Solutions increased its DexCom (DXCM) stake by 1.1% in Q1 2026, buying an estimated $30.2K and bringing the position to 39,851 shares worth $2.5M. The position accounts for 0.03% of the portfolio, ranked #308.

ABN AMRO Investment Solutions first reported a position in DXCM in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.94M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

ABN AMRO Investment Solutions held 39,851 shares of DexCom worth $2.5M as of Q1 2026.
ABN AMRO Investment Solutions bought 433 DexCom shares in Q1 2026, an estimated $30.2K.
DexCom made up 0.03% of ABN AMRO Investment Solutions's portfolio in Q1 2026, its #308 holding.
ABN AMRO Investment Solutions first reported a position in DexCom in Q1 2023 and has held it in 13 quarters since.
ABN AMRO Investment Solutions's DexCom position peaked at $3.94M in Q2 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q1 2026, filed 12 May 2026.